Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuropathy arising from inflammation of one or more nerves.
Biomarker and diagnostic research for neuritis has been reported in the published literature.
22 clinical trials registered, 14 recruiting. Interventions under study include other interventions, drug therapy, and medical devices. Pipeline includes 2 PHASE3, 5 PHASE2, 7 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT03401879](https://clinicaltrials.gov/study/NCT03401879) |
Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 5:07 PM UTC
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis |
NA |
Medical University of Vienna |
RECRUITING |
[NCT04678167](https://clinicaltrials.gov/study/NCT04678167) | Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis | NA | University Hospital, Brest | RECRUITING |
[NCT05424302](https://clinicaltrials.gov/study/NCT05424302) | Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy | NA | University of British Columbia | RECRUITING |
[NCT02521311](https://clinicaltrials.gov/study/NCT02521311) | Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) | PHASE2 | University of California, San Francisco | RECRUITING |
[NCT05540262](https://clinicaltrials.gov/study/NCT05540262) | Edaravone in the Treatment of Optic Neuritis | NA | First Affiliated Hospital of Guangxi Medical University | RECRUITING |
289 publications have been identified in PubMed for neuritis. Kisho has analyzed 171 by research type. Research spans Review / Meta-Analysis (26%), Case Report / Case Series (22%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 45 | 26% |
Patient case studies | 38 | 22% |
Disease patterns and progression | 24 | 14% |
Laboratory research | 22 | 13% |
Testing and diagnosis research | 21 | 12% |
Other research | 8 | 5% |
Clinical study results | 7 | 4% |
New treatment approaches | 6 | 4% |
Malkawi L (2026). [PMID: 41922033](https://pubmed.ncbi.nlm.nih.gov/41922033/). *Neurol Clin*. [Review / Meta-Analysis]
Sasaki R (2026). [PMID: 40967794](https://pubmed.ncbi.nlm.nih.gov/40967794/). *Intern Med*. [Case Report / Case Series]
Unknown (2026). [PMID: 42133961](https://pubmed.ncbi.nlm.nih.gov/42133961/). *J Neuroophthalmol*. [Review / Meta-Analysis]
Finley R (2026). [PMID: 42157713](https://pubmed.ncbi.nlm.nih.gov/42157713/). *Ocul Immunol Inflamm*. [Case Report / Case Series]
Xi L (2026). [PMID: 42244326](https://pubmed.ncbi.nlm.nih.gov/42244326/). *Zhong Nan Da Xue Xue Bao Yi Xue Ban*. [Case Report / Case Series]
Gu T (2026). [PMID: 41206312](https://pubmed.ncbi.nlm.nih.gov/41206312/). *Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics*. [Gene Therapy / Novel Therapeutics]
Somani S (2026). [PMID: 42039307](https://pubmed.ncbi.nlm.nih.gov/42039307/). *J Am Acad Audiol*. [Basic Science / Preclinical]
Lin YH (2026). [PMID: 41490291](https://pubmed.ncbi.nlm.nih.gov/41490291/). *QJM*. [Case Report / Case Series]
Delikaya M (2026). [PMID: 41688447](https://pubmed.ncbi.nlm.nih.gov/41688447/). *Expert Rev Neurother*. [Review / Meta-Analysis]
Law L (2026). [PMID: 29489178](https://pubmed.ncbi.nlm.nih.gov/29489178/). *Unknown Journal*. [Other]